ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

32,541Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 2056

$1.52M Total Retail Price of All Prescriptions

Rank: 3 out of 2056

797 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
87% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

20% of this provider’s 797 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

10% of this provider’s 797 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 24,100 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
FUROSEMIDE 1,139 933 1 9
WARFARIN SODIUM 1,107 834 2 12
LISINOPRIL 1,101 871 3 1
SIMVASTATIN 1,069 836 4 2
LEVOTHYROXINE SODIUM 889 672 5 3
CITALOPRAM HBR 886 592 6 15
METOPROLOL TARTRATE 856 653 7 11
OMEPRAZOLE 831 608 8 4
RISPERIDONE 764 628 9 48
AMLODIPINE BESYLATE 578 488 10 6
TRAMADOL HCL 575 464 11 27
GABAPENTIN 569 350 12 14
POTASSIUM CHLORIDE 568 444 13 18
POLYETHYLENE GLYCOL 3350 516 395 14 50
LANTUS 477 330 15 41
NOVOLOG 474 346 16 96
MELOXICAM 436 360 17 47
MIRTAZAPINE 416 348 18 45
DONEPEZIL HCL 413 388 19 37
OXYCODONE HCL 381 201 S2 20 24
METFORMIN HCL 363 220 21 8
TAMSULOSIN HCL 352 267 22 28
RANITIDINE HCL 349 265 23 22
FENTANYL 344 264 S2 24 56
QUETIAPINE FUMARATE 334 274 25 61
TRAZODONE HCL 317 196 26 21
DIVALPROEX SODIUM 297 231 27 69
NAMENDA 296 262 28 62
HYDROCODONE-ACETAMINOPHEN 291 222 S3 29 5
ATENOLOL 280 262 30 10
MORPHINE SULFATE ER 276 141 S2 31 36
CYMBALTA 275 171 32 59
HYDROCHLOROTHIAZIDE 260 212 33 7
CARVEDILOL 251 159 34 35
PANTOPRAZOLE SODIUM 242 155 35 55
OXYBUTYNIN CHLORIDE ER 236 190 36 135
SERTRALINE HCL 229 163 37 25
ATORVASTATIN CALCIUM 221 151 38 17
DIGOXIN 217 187 39 53
BACLOFEN 216 89 40 86
GLIPIZIDE 213 195 41 39
METOPROLOL SUCCINATE 201 174 42 19
CLOPIDOGREL 194 154 43 72
ALLOPURINOL 193 156 44 32
PHENYTOIN SODIUM EXTENDED 191 158 45 143
IPRATROPIUM-ALBUTEROL 186 159 46 137
FLUOXETINE HCL 181 113 47 33
ADVAIR DISKUS 177 165 48 51
CARBIDOPA-LEVODOPA 174 165 49 101
PREDNISONE 166 124 50 38
SPIRIVA 153 127 51 42
LOSARTAN POTASSIUM 144 116 52 13
FLUTICASONE PROPIONATE 140 74 53 31
OXYCODONE-ACETAMINOPHEN 140 78 S2 53 40
ISOSORBIDE MONONITRATE ER 131 118 55 87
DILTIAZEM 24HR CD 128 111 56 120
ALENDRONATE SODIUM 126 102 57 26
SPIRONOLACTONE 124 84 58 63
METOCLOPRAMIDE HCL 124 33 58 114
LEVETIRACETAM 117 75 60 134
LOVASTATIN 114 106 61 16
KLOR-CON M20 111 72 62 173
HEPARIN SODIUM 107 48 63 282
DIOVAN 105 92 64 68
LEVEMIR 104 64 65 233
SULFAMETHOXAZOLE-TRIMETHOPRIM 103 83 66 116
FENOFIBRATE 103 75 66 64
PAROXETINE HCL 100 82 68 58
CEFTRIAXONE 100 84 68 205
GEMFIBROZIL 99 82 70 108
LANTUS SOLOSTAR 96 86 71 80
PRAVASTATIN SODIUM 96 93 71 20
AMITRIPTYLINE HCL 95 44 R 73 60
CARBAMAZEPINE 95 49 73 174
ROPINIROLE HCL 94 88 75 98
NYSTOP 93 62 76 218
HUMALOG 92 56 77 163
VALPROIC ACID 91 54 78 258
OLANZAPINE 91 78 78 83
FAMOTIDINE 90 61 80 89
CYCLOBENZAPRINE HCL 89 37 R 81 52
LEVOFLOXACIN 89 77 81 141
ESCITALOPRAM OXALATE 89 67 81 118
ABILIFY 88 51 84 152
SEROQUEL 86 80 85 142
PLAVIX 83 62 86 131
VENLAFAXINE HCL ER 82 51 87 82
CEPHALEXIN 81 59 88 125
LISINOPRIL-HYDROCHLOROTHIAZIDE 80 76 89 34
NITROFURANTOIN MONO-MACRO 80 64 89 220
RENVELA 79 29 91 298
LAMOTRIGINE 77 33 92 107
SPIRONOLACTONE-HCTZ 74 74 93 219
PROAIR HFA 71 46 94 29
DILTIAZEM ER 69 61 95 129
LATANOPROST 67 57 96 221
LOSARTAN-HYDROCHLOROTHIAZIDE 65 54 97 78
TRIAMCINOLONE ACETONIDE 65 34 97 81
FLOVENT HFA 65 38 97 149
ENOXAPARIN SODIUM 64 49 100 251
CLONIDINE HCL 63 45 101 92
PRIMIDONE 62 61 102 323
SPS 61 56 103 325
NITROGLYCERIN PATCH 59 59 104 237
SINGULAIR 59 48 104 164
ZOLPIDEM TARTRATE 59 41 104 23
PROMETHAZINE HCL 59 19 R 104 127
NIASPAN 59 24 104 126
VENTOLIN HFA 58 44 109 109
DILANTIN 57 39 110 279
FINASTERIDE 57 50 110 90
HYDRALAZINE HCL 57 41 110 168
TRIAMTERENE-HCTZ 56 28 113 46
ENULOSE 55 11 114 338
HYDROMORPHONE HCL 55 0 S2 114 140
PROPRANOLOL HCL 55 38 114 123
ALBUTEROL SULFATE 55 44 114 167
NORTRIPTYLINE HCL 52 26 118 100
BUPROPION HCL SR 51 24 119 104
MORPHINE SULFATE 50 31 S2 120 157
METHADONE HCL 50 25 S2 120 49
CIPROFLOXACIN HCL 50 32 120 105
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 13, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.